EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification

Chunsheng Lin, Qianqian Tian, Sifan Guo, Dandan Xie, Ying Cai iD, Zhibo Wang, Hang Chu, Shi Qiu, Songqi Tang iD, Aihua Zhang iD

Molecules · 08.05.2024 · 29 (10) · 2198

DOI: 10.3390/molecules29102198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 08.05.2024. Verfasst von Chunsheng Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School and Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: Metabolomics, Biomarkers, Mass Spectrometry. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program of Natural Science Foundation of State, Hainan Provincial Department of Science and Technology, Natural Science Foundation of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As links between genotype and phenotype, small-molecule metabolites are attractive biomarkers for disease diagnosis, prognosis, classification, drug screening and treatment, insight into understanding disease pathology and identifying potential targets. Metabolomics technology is crucial for discovering targets of small-molecule metabolites involved in disease phenotype. Mass spectrometry-based metabolomics has implemented in applications in various fields including target discovery, explanation of disease mechanisms and compound screening. It is used to analyze the physiological or pathological states of the organism by investigating the changes in endogenous small-molecule metabolites and associated metabolism from complex metabolic pathways in biological samples. The present review provides a critical update of high-throughput functional metabolomics techniques and diverse applications, and recommends the use of mass spectrometry-based metabolomics for discovering small-molecule metabolite signatures that provide valuable insights into metabolic targets. We also recommend using mass spectrometry-based metabolomics as a powerful tool for identifying and understanding metabolic patterns, metabolic targets and for efficacy evaluation of herbal medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsBiomarkersMass SpectrometryHumansDrug DiscoveryMetabolomeAnimals

Stichwörter der Autor:innen

biomarkermass spectrometrymetabolomicsphenotypetargets

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Graduate School and Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
  • Faculty of Social Sciences, The University of Hong Kong, Hong Kong 999077, China.
  • International Advanced Functional Omics Platform, Scientific Experiment Center, International Joint Research Center on Traditional Chinese and Modern Medicine, Hainan Engineering Research Center for Biological Sample Re…
  • Department of Biomedical Sciences, Beijing City University, Beijing 100193, China.

ORCID-Profile: Ying Cai, Songqi Tang, Aihua Zhang

Förderung

  • Program of Natural Science Foundation of State
  • Hainan Provincial Department of Science and Technology
  • Natural Science Foundation of Heilongjiang Province

Zitieren

APA

Lin, C., Tian, Q., Guo, S., Xie, D., Cai, Y., Wang, Z., Chu, H., Qiu, S., Tang, S., & Zhang, A. (2024). Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification. Molecules, 29(10), 2198. https://doi.org/10.3390/molecules29102198

Vancouver

Lin C, Tian Q, Guo S, Xie D, Cai Y, Wang Z, et al. Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification. Molecules. 2024;29(10):2198. doi:10.3390/molecules29102198

BibTeX
@article{Lin2024,
  author = {Lin, Chunsheng and Tian, Qianqian and Guo, Sifan and Xie, Dandan and Cai, Ying and Wang, Zhibo and Chu, Hang and Qiu, Shi and Tang, Songqi and Zhang, Aihua},
  title = {Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {10},
  pages = {2198},
  doi = {10.3390/molecules29102198}
}
Kostenlos starten →